can i switch from retatrutide to tirzepatide Switching and What You Should Know Before Making the Change switching from retatrutide to tirzepatide

Locate available third-party analytical records and review documented results

Gout J, Perkhofer L, Morawe M, et al

Cureus, 17 (2), e78785

#AscendisPharma #NovoNordisk #TransConTechnology #MetabolicDiseases #CardiovascularDiseases #Biopharma #HealthcareInnovation #GLP1 bioSeedins Post Ascendis Pharma (Nasdaq: ASND) Ascendis Pharma has granted Novo Nordisk (NYSE: NVO) Novo Nordisk an exclusive license to use its TransCon technology platform for developing treatments in metabolic diseases, including obesity and type 2 diabetes, and on a product-specific basis for cardiovascular diseases

February 2025 A study published January 30, 2025, found that medications like Ozempic and Mounjaro, commonly used to treat diabetes and aid in weight loss, may be linked to rare eye conditions that can cause vision loss or even blindness

We usually think of medication as a treatment, but thats changing